Nature’s Sunshine Products (NASDAQ:NATR) EVP Daniel Norman Sells 8,884 Shares

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) EVP Daniel Norman sold 8,884 shares of the business’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $20.46, for a total transaction of $181,766.64. Following the sale, the executive vice president owned 66,636 shares in the company, valued at $1,363,372.56. This trade represents a 11.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Nature’s Sunshine Products Price Performance

Shares of NASDAQ NATR traded down $0.96 during midday trading on Wednesday, hitting $19.86. The company’s stock had a trading volume of 83,154 shares, compared to its average volume of 79,353. The firm has a market capitalization of $347.47 million, a price-to-earnings ratio of 26.84 and a beta of 1.09. The business’s fifty day simple moving average is $15.92 and its two-hundred day simple moving average is $15.47. Nature’s Sunshine Products, Inc. has a 1 year low of $11.01 and a 1 year high of $21.64.

Nature’s Sunshine Products (NASDAQ:NATR) last released its earnings results on Thursday, November 6th. The company reported $0.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.18 by $0.18. The company had revenue of $88.99 million for the quarter, compared to analyst estimates of $119.39 million. Nature’s Sunshine Products had a net margin of 3.06% and a return on equity of 10.19%. Nature’s Sunshine Products has set its FY 2025 guidance at EPS.

Institutional Trading of Nature’s Sunshine Products

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. MTM Investment Management LLC purchased a new stake in shares of Nature’s Sunshine Products during the second quarter worth approximately $30,000. CWM LLC increased its stake in Nature’s Sunshine Products by 147.0% in the 3rd quarter. CWM LLC now owns 2,075 shares of the company’s stock valued at $32,000 after buying an additional 1,235 shares during the period. Raymond James Financial Inc. purchased a new position in Nature’s Sunshine Products during the 2nd quarter worth $37,000. Williams & Novak LLC acquired a new stake in shares of Nature’s Sunshine Products in the 2nd quarter worth $155,000. Finally, Russell Investments Group Ltd. lifted its stake in shares of Nature’s Sunshine Products by 351.2% in the 1st quarter. Russell Investments Group Ltd. now owns 12,398 shares of the company’s stock worth $156,000 after acquiring an additional 9,650 shares during the period. 79.40% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on NATR shares. DA Davidson upped their target price on shares of Nature’s Sunshine Products from $21.00 to $23.00 and gave the stock a “buy” rating in a research note on Monday, November 10th. Weiss Ratings reissued a “hold (c)” rating on shares of Nature’s Sunshine Products in a report on Wednesday, October 8th. Finally, Canaccord Genuity Group raised their price target on Nature’s Sunshine Products from $21.00 to $22.00 and gave the stock a “buy” rating in a research note on Friday, August 1st. Two investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, Nature’s Sunshine Products presently has an average rating of “Moderate Buy” and a consensus price target of $22.50.

About Nature’s Sunshine Products

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.